Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Government and Novatek to invest ₽24.3 billion to build LNG equipment

4/4/24 NVTK

Delimobil reported 2023 by IFRS

4/4/24 DELI

Softline reported for 2023 by RAS

4/3/24 SOFL

Ingrad reported for 2023 by RAS

4/3/24 INGR

Sollers in Q1 increased sales by 30%

4/3/24 SVAV

UWC reported for 2023 by RAS

4/3/24 UWGN

Lukoil reduced production but maintained oil exports

4/3/24 LKOH

Prepared Pre-IPO of a subsidiary of a major real estate developer

4/3/24 OTCI

Positive Technologies has entered a new market segment

4/3/24 POSI

M.Video-Eldorado opened 15 compact format stores

4/3/24 MVID